BPG is committed to discovery and dissemination of knowledge
Minireviews
Copyright: ©Author(s) 2026.
World J Clin Pediatr. Jun 9, 2026; 15(2): 114189
Published online Jun 9, 2026. doi: 10.5409/wjcp.v15.i2.114189
Table 1 TRPM4 variants electrophysiologically studied
Substitution
Variant
Location
Effect
Underlying mechanism
Protein expression level on membrane
Current density
Ca2+ dependence
Voltage-dependence
Electrophysiological results
Classification
ECG morphology; phenotype
Ref.
p.E7Kc.19G>AN-terminus. Putative CaM binding siteGoFImpaired SUMOylation (attenuated deSUMOylation). Impaired endocytosis
Enhanced interaction of PIP2 and TRPM4 protein (increased risk of generating triggered activities)
↑↑Prolonged AP (due to facilitated open state condition). Depolarizing shifts of the resting membrane potential (depending on the channel density or maximal activity). Insensitivityto PIP2 depletionPathogenicPFHB1B, RBBB, progressive conduction block[30,49]
p. R164Wc.490C>TN-terminusGoFNo changes↑No changesNo effect on SUMOylation stimulation. Dynamitin-insensitivePathogenicPFHB1B[48]
p.D198GPutative CaM binding siteNo changesNo changesUncertain significance[50,51]
p.A432Tc.1294G>AN-terminusGoFLikely to be caused by protein misfolding and retention in the endoplasmic reticulum ↓↓No changesCotransfection experiments of TRPM4 mutants with Ubc9 showed an increase of current density (stimulating effect on SUMOylation). Dynamitin-insensitive. Lowering the incubation temperature of cells expressing the variant to 28 °C for 24 hours increased their expression both at the total level (A432T 78% ± 3% of WT); and at the cell surface level (A432T 72% ± 8% of WT). A significant increase in the current density of A432T was observed (599 ± 104 pA/pF at 28 °C vs 230 ± 27 pA/pF at 37 °C), whereas WT showed no significant change (639 ± 101 pA/pF at 28 °C vs 553 ± 74 pA/pF at 37 °C;P > 0.05) PathogenicPFHB1A. PFHB1B. Atrioventricular block. Brugada syndrome[49]
p.A432T/G582S N-terminusLoFLikely to be caused by protein misfolding and retention in the endoplasmic reticulum ↓No changesLowering the incubation temperature of cells expressing the variant to 28 °C for 24 hours increased their expression both at the total level (A432T/G582S 69% ± 5% of WT) and at the cell surface level (A432T/G582S 65% ± 7% of WT)
p.V441MLoF↓[49]
p.R499WLoF↓[48]
p.G582Sc.1744G>AN-terminusGoFDirect SUMOylation of TRPM4 is unlikely to be linked to the increased expression and gain of function of the variant↑↑ (171% ± 20% of WT)PathogenicPFHB1A. PFHB1B. Brugada syndrome[48]
p.T677IN-terminusNo changesNo changesUncertain significance
p. P779Rc.2336C>GTM2↓↓↓V1/2 ↑Uncertain significanceBrugada syndrome. Right bundle brunch block
p.G844Dc.2531G>AABC-motifGoFNo changes↑No changesCotransfection experiments of TRPM4 mutants with Ubc9 showed an increase of current density (stimulating effect on SUMOylation). Dynamitin-insensitivePathogenicPFHB1B right bundle-branch block. Brugada syndrome. Long QT syndrome[48]
p.T873Ic.2618C>TTM3↑↓No changesUncertain significance[48]
p.K914Xc.2740A>TPutative SUMOylation siteNon-functional channel↓No current↓No changesLikely benignPFHB1B right bundle-branch block[52]
p.V921Ic.2761G>ATM4-TM5 No changesNo significant changesLikely benignPFHB1B[49,53]
p.L1075Pc.3224T>CC-terminus↑↓↓No changes
Uncertain significancePFHB1B
Table 2 Genetic variants identified in patients
Patients
Gene
GRCh38
Nucleotide change
Amino acid change
db SNP, MAF%
CADD
SIFTcat
PolyPhenCat
Patient 1TRPM4Chr19:49200722, NM 017636.4: C.C2890Ap.Arg964Serrs749078579, 0.001592%26DeleteriousPD
Patient 2TRPM4Chr19:49210799NM 017636.4: C.A3418Tp.Lys1140TerNo data45NANA
Patient 2MYPNChr10: 68201958 NM 032578.4: C.A3623Tp.Asp1208ValNo data32DeleteriousPD


Write to the Help Desk